5-ALA for pediatric brain tumor surgery
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether a drug called 5-ALA (which helps surgeons see tumor cells more clearly during surgery) is safe and effective in children with certain brain tumors. It is given as a liquid before surgery, and the goal is to help the surgeon remove more of the tumor while protecting healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 2 and 17 years old.
- Must have a brain tumor that is planned to be removed with surgery.
- The tumor type must be one of the specific types listed (e.g., pilocytic astrocytoma, medulloblastoma).
- Must have normal organ and bone marrow function (based on routine blood tests).
- Must be able to swallow the liquid drug and have no history of porphyria in the family.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
This trial tests a combination of antiangiogenic drugs (which block blood supply to tumors) for children with certain brain or spinal tumors that have returned or not responded to standard treatment. The goal is to see if this drug combo can shrink or slow the tumor.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a new approach that combines a drug (SONALA-001 or 5-ALA) with focused ultrasound to treat glioblastoma that has come back or is growing despite standard treatments. The drug makes tumor cells sensitive to sound waves, and the ultrasound waves are directed at the tumor using MRI guidance. This may help damage cancer cells while sparing healthy brain tissue.
Hear when a new Pediatric Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.